Mirae Asset Global Investments
EDIT icon

Mirae Asset Global Investments’s Editas Medicine EDIT Stock Holding History

Mirae Asset Global Investments’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2K Buy
6,863
+1,771
+35% +$5.18K ﹤0.01% 1475
2026
Q1 		$12.6K Buy
5,092
+348
+7% +$736 ﹤0.01% 1479
2025
Q4 		$9.72K Buy
4,744
+1,268
+36% +$3.66K ﹤0.01% 1603
2025
Q3 		$12.1K Buy
3,476
+242
+7% +$675 ﹤0.01% 1552
2025
Q2 		$7.12K Buy
3,234
+512
+19% +$838 ﹤0.01% 1525
2025
Q1 		$3.4K Sell
2,722
-29
-1% -$43 ﹤0.01% 1525
2024
Q4 		$3.33K Sell
2,751
-232
-8% -$591 ﹤0.01% 1572
2024
Q3 		$10.4K Buy
2,983
+528
+22% +$2.3K ﹤0.01% 1495
2024
Q2 		$11.6K Sell
2,455
-312,319
-99% -$1.76M ﹤0.01% 1450
2024
Q1 		$2.25M Buy
314,774
+116,803
+59% +$971K ﹤0.01% 1144
2023
Q4 		$2.01M Sell
197,971
-177,556
-47% -$1.56M ﹤0.01% 1256
2023
Q3 		$2.93M Buy
375,527
+26,230
+8% +$225K 0.01% 1026
2023
Q2 		$2.87M Buy
349,297
+31,420
+10% +$274K 0.01% 1053
2023
Q1 		$2.3M Buy
317,877
+28,275
+10% +$251K 0.01% 1152
2022
Q4 		$2.57M Sell
289,602
-63,137
-18% -$693K 0.01% 1039
2022
Q3 		$4.32M Buy
352,739
+46,080
+15% +$718K 0.01% 858
2022
Q2 		$3.63M Buy
306,659
+89,458
+41% +$1.2M 0.01% 937
2022
Q1 		$4.13M Sell
217,201
-43,810
-17% -$814K 0.01% 939
2021
Q4 		$6.93M Buy
261,011
+55,940
+27% +$1.93M 0.01% 792
2021
Q3 		$8.42M Buy
205,071
+38,454
+23% +$2.11M 0.02% 703
2021
Q2 		$9.44M Buy
166,617
+28,041
+20% +$1.04M 0.03% 655
2021
Q1 		$5.82M Buy
138,576
+62,711
+83% +$3.57M 0.02% 703
2020
Q4 		$5.32M Buy
75,865
+25,173
+50% +$1.03M 0.02% 638
2020
Q3 		$1.42M Buy
50,692
+15,921
+46% +$519K 0.01% 869
2020
Q2 		$1.03M Buy
34,771
+14,926
+75% +$390K 0.01% 896
2020
Q1 		$393K Buy
19,845
+2,166
+12% +$54.6K ﹤0.01% 1101
2019
Q4 		$524K Buy
17,679
+2,419
+16% +$60.4K ﹤0.01% 1203
2019
Q3 		$347K Buy
+15,260
New +$378K ﹤0.01% 1274

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's EDIT Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Editas Medicine (EDIT) stake by 35% in Q2 2026, buying an estimated $5.18K and bringing the position to 6,863 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1475.

Mirae Asset Global Investments first reported a position in EDIT in Q3 2019 and has held it in 28 quarters since. The position peaked at $9.44M in Q2 2021. 79 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Mirae Asset Global Investments held 6,863 shares of Editas Medicine worth $22.2K as of Q2 2026.
  • Mirae Asset Global Investments bought 1,771 Editas Medicine shares in Q2 2026, an estimated $5.18K.
  • Editas Medicine made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1475 holding.
  • Mirae Asset Global Investments first reported a position in Editas Medicine in Q3 2019 and has held it in 28 quarters since.
  • Mirae Asset Global Investments's Editas Medicine position peaked at $9.44M in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.